688136

Kexing Biopharm
688136

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN„9.69B
EV
CN„10.37B
Shares Outstanding
197.76M
Beta
1.03

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN„42.00
P/E 2025E
89.11x
P/Revenue 2025E
5.24x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Kexing Biopharm Co., Ltd.

gainify
688136

Kexing Biopharm Co., Ltd.

688136

Kexing Biopharm Co., Ltd. engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally. The company focuses on pharmaceutical research in the therapeutic fields of antiviral, tumor a...

Sector

Healthcare

Industry

Biotechnology

CEO

Zhao, Yanqing

Employees

947

IPO Date

2020-12-14

Headquarters

No. 2666 Chuangye Road, Bucun Street, Zhangqiu District, Jinan, Shandong Province, 250200, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.